Literature DB >> 6573906

Distribution of 4'epi-doxorubicin in human tissues.

C Italia, L Paglia, A Trabattoni, S Luchini, F Villas, L Beretta, G Marelli, N Natale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573906      PMCID: PMC2011320          DOI: 10.1038/bjc.1983.86

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  Plasma and urinary levels of adriamycin in man.

Authors:  R Rosso; C Ravazzoni; M Esposito; R Sala; L Santi
Journal:  Eur J Cancer       Date:  1972-08       Impact factor: 9.162

2.  In vitro uptake and cytotoxicity of adriamycin in primary and metastatic Lewis lung carcinoma.

Authors:  M G Donelli; B Barbieri; E Erba; M A Pacciarini; A Salmona; S Garattini; L Morasca
Journal:  Eur J Cancer       Date:  1979-09       Impact factor: 9.162

3.  Preliminary phase I study of 4'-epi-adriamycin.

Authors:  V Bonfante; G Bonadonna; F Villani; G Di Fronzo; A Martini; A M Casazza
Journal:  Cancer Treat Rep       Date:  1979-05

4.  Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.

Authors:  K K Chan; J L Cohen; J F Gross; K J Himmelstein; J R Bateman; Y Tsu-Lee; A S Marlis
Journal:  Cancer Treat Rep       Date:  1978-08

5.  Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.

Authors:  M Broggini; T Colombo; A Martini; M G Donelli
Journal:  Cancer Treat Rep       Date:  1980 Aug-Sep

6.  Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.

Authors:  R S Benjamin; C E Riggs; N R Bachur
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

  6 in total
  3 in total

Review 1.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

2.  Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma.

Authors:  P A Speth; P C Linssen; L V Beex; J B Boezeman; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of epirubicin.

Authors:  J Robert
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.